Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 USD | -4.71% | -8.18% | +24.69% |
Financials (USD)
Sales 2024 * | 833K | Sales 2025 * | 4.6M | Capitalization | 334M |
---|---|---|---|---|---|
Net income 2024 * | -127M | Net income 2025 * | -136M | EV / Sales 2024 * | 326 x |
Net cash position 2024 * | 61.98M | Net cash position 2025 * | 61.76M | EV / Sales 2025 * | 59.1 x |
P/E ratio 2024 * |
-2.7
x | P/E ratio 2025 * |
-2.71
x | Employees | 140 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.29% |
Latest transcript on Tenaya Therapeutics, Inc.
1 day | -8.80% | ||
1 week | -0.70% | ||
Current month | -6.39% | ||
1 month | -1.62% | ||
3 months | -18.89% | ||
6 months | +126.67% | ||
Current year | +31.17% |
Managers | Title | Age | Since |
---|---|---|---|
Faraz Ali
CEO | Chief Executive Officer | 51 | 18-05-31 |
Leone Patterson
DFI | Director of Finance/CFO | 61 | 21-05-31 |
Kee-Hong Kim
CTO | Chief Tech/Sci/R&D Officer | - | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 16-09-30 |
David Goeddel
CHM | Chairman | 72 | 16-07-31 |
Jeffrey Walsh
BRD | Director/Board Member | 58 | 20-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.49% | - | |
0.00% | 17 M€ | +5.97% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 4.04 | -4.94% | 406 404 |
24-05-20 | 4.25 | -8.80% | 267,116 |
24-05-17 | 4.66 | +9.65% | 613,440 |
24-05-16 | 4.25 | 0.00% | 356,473 |
24-05-15 | 4.25 | -3.41% | 332,007 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.17% | 334M | |
+41.79% | 54.04B | |
+46.06% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- TNYA Stock